Molecular Landscape of Pelvic Organ Prolapse Provides Insights into Disease Etiology
暂无分享,去创建一个
L. Kiemeney | J. Goeman | S. Vermeulen | G. Poelmans | E. Oosterwijk | A. M. Ruiz-Zapata | S. Lince | Joanna Widomska | W. Post | M. Kerkhof | Ward De Witte | Kirsten B Kluivers | Rufus Cartwright | Jakub Pecanka | Kristina Allen-Brady
[1] K. Kluivers,et al. Risk factors for primary pelvic organ prolapse and prolapse recurrence: an updated systematic review and meta-analysis. , 2022, American journal of obstetrics and gynecology.
[2] G. Gurusubramanian,et al. Effects of metformin on the uterus of d-galactose-induced aging mice: Histomorphometric, immunohistochemical localization (B-cell lymphoma 2, Bcl2-associated X protein, and active capase3), and oxidative stress study. , 2022, Journal of experimental zoology. Part A, Ecological and integrative physiology.
[3] M. Hellerstein,et al. Transcriptome and proteome dynamics of cervical remodeling in the mouse during pregnancy , 2021, Biology of Reproduction.
[4] M. Shahhoseini,et al. Metformin attenuates expression of angiogenic and inflammatory genes in human endometriotic stromal cells. , 2021, Experimental cell research.
[5] M. Carazzolle,et al. Evidence of macrophage modulation in the mouse pubic symphysis remodeling during the end of first pregnancy and postpartum , 2020, Scientific Reports.
[6] K. Kluivers,et al. Extracellular Matrix Stiffness and Composition Regulate the Myofibroblast Differentiation of Vaginal Fibroblasts , 2020, International journal of molecular sciences.
[7] Hannes P. Eggertsson,et al. Genome-wide association identifies seven loci for pelvic organ prolapse in Iceland and the UK Biobank , 2020, Communications Biology.
[8] L. Cannon-Albright,et al. Risk of Pelvic Organ Prolapse Treatment Based on Extended Family History. , 2020, American journal of obstetrics and gynecology.
[9] A. Vetuschi,et al. Immunolocalization of Advanced Glycation End Products, Mitogen Activated Protein Kinases, and Transforming Growth Factor-β/Smads in Pelvic Organ Prolapse , 2018, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[10] Kevin Chagin,et al. Predicting risk of pelvic floor disorders 12 and 20 years after delivery , 2017, American journal of obstetrics and gynecology.
[11] L. Salnikova,et al. Expression changes in pelvic organ prolapse: a systematic review and in silico study , 2017, Scientific Reports.
[12] T. Gasser,et al. Integrated molecular landscape of Parkinson’s disease , 2017, npj Parkinson's Disease.
[13] L. Kiemeney,et al. Cohort Profile Cohort Profile : The Nijmegen Biomedical Study ( NBS ) , 2017 .
[14] X. Fang,et al. Metformin is a novel suppressor for transforming growth factor (TGF)-β1 , 2016, Scientific Reports.
[15] T. Smit,et al. Vaginal Fibroblastic Cells from Women with Pelvic Organ Prolapse Produce Matrices with Increased Stiffness and Collagen Content , 2016, Scientific Reports.
[16] B. Franke,et al. Prioritization and burden analysis of rare variants in 208 candidate genes suggest they do not play a major role in CAKUT. , 2016, Kidney international.
[17] Hui Zhang,et al. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells , 2016, Oncotarget.
[18] Yong He,et al. Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathway , 2015, Oncotarget.
[19] C. Liu,et al. Oxidative damage to human parametrial ligament fibroblasts induced by mechanical stress. , 2015, Molecular medicine reports.
[20] J. Jung,et al. Clinicopathological significance of N-cadherin and VEGF in advanced gastric cancer brain metastasis and the effects of metformin in preclinical models. , 2015, Oncology reports.
[21] K. Kluivers,et al. Risk factors for pelvic organ prolapse and its recurrence: a systematic review , 2015, International Urogynecology Journal.
[22] M. Horinaka,et al. Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells , 2015, PloS one.
[23] Jianhua Shi,et al. Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts. , 2015, Life sciences.
[24] Phillip R. Bennett,et al. Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women , 2015, American journal of obstetrics and gynecology.
[25] Raphael Gottardo,et al. Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.
[26] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[27] T. Baer,et al. Proliferative behavior of vaginal fibroblasts from women with pelvic organ prolapse. , 2014, European journal of obstetrics, gynecology, and reproductive biology.
[28] J. Schaffer,et al. Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial. , 2014, The Journal of clinical endocrinology and metabolism.
[29] Jennifer M Wu,et al. Lifetime Risk of Stress Urinary Incontinence or Pelvic Organ Prolapse Surgery , 2014, Obstetrics and gynecology.
[30] S. Ye,et al. Metformin inhibits nuclear factor‐&kgr;B activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate‐activated protein kinase activation in rat glomerular mesangial cells in vitro , 2014, Chinese medical journal.
[31] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[32] P. Parrino,et al. Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin , 2013, Molecular and Cellular Endocrinology.
[33] B. Franke,et al. AKAPs integrate genetic findings for autism spectrum disorders , 2013, Translational Psychiatry.
[34] T. Smit,et al. Fibroblasts from women with pelvic organ prolapse show differential mechanoresponses depending on surface substrates , 2013, International Urogynecology Journal.
[35] K. Korach,et al. The absence of ER-β results in altered gene expression in ovarian granulosa cells isolated from in vivo preovulatory follicles. , 2013, Endocrinology.
[36] N. Chung,et al. Involvement of oxidative stress and mitochondrial apoptosis in the pathogenesis of pelvic organ prolapse. , 2013, The Journal of urology.
[37] Patrick F. Sullivan,et al. zCall: a rare variant caller for array-based genotyping: Genetics and population analysis , 2012, Bioinform..
[38] Ewout J. N. Groen,et al. Mapping of Gene Expression Reveals CYP27A1 as a Susceptibility Gene for Sporadic ALS , 2012, PloS one.
[39] K. Kluivers,et al. A systematic review of clinical studies on hereditary factors in pelvic organ prolapse , 2012, International Urogynecology Journal.
[40] L. Cannon-Albright,et al. Identification of Six Loci Associated With Pelvic Organ Prolapse Using Genome-Wide Association Analysis , 2011, Obstetrics and gynecology.
[41] Fionn Murtagh,et al. Ward’s Hierarchical Agglomerative Clustering Method: Which Algorithms Implement Ward’s Criterion? , 2011, Journal of Classification.
[42] Jin-Ying Zhang,et al. Beneficial effects of metformin on primary cardiomyocytes via activation of adenosine monophosphate-activated protein kinase. , 2011, Chinese medical journal.
[43] L. Hong,et al. Expression of transforming growth factor-beta 1 and connective tissue growth factor in women with pelvic organ prolapse. , 2011, Saudi medical journal.
[44] B. Franke,et al. Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. , 2011, The American journal of psychiatry.
[45] B. Howard,et al. Risk Factors for Prolapse Development in White, Black, and Hispanic Women , 2011, Female pelvic medicine & reconstructive surgery.
[46] B. Martín-Castillo,et al. Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis , 2010, Cell cycle.
[47] S. Abramowitch,et al. Repetitive Mechanical Stretch Increases Extracellular Collagenase Activity in Vaginal Fibroblasts , 2010, Female pelvic medicine & reconstructive surgery.
[48] Yi Zhu,et al. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway. , 2010, Cardiovascular research.
[49] J. Mauskopf,et al. Rate, type, and cost of pelvic organ prolapse surgery in Germany, France, and England. , 2009, European journal of obstetrics, gynecology, and reproductive biology.
[50] M. Eijkemans,et al. The prevalence of pelvic organ prolapse symptoms and signs and their relation with bladder and bowel disorders in a general female population , 2009, International Urogynecology Journal.
[51] O. Nyrén,et al. Nonobstetric Risk Factors for Symptomatic Pelvic Organ Prolapse , 2009, Obstetrics and gynecology.
[52] P. Lichtenstein,et al. Genetic influence on stress urinary incontinence and pelvic organ prolapse. , 2008, European urology.
[53] Tetsuo Yamada,et al. The identification and structural characterization of C7orf24 as gamma-glutamyl cyclotransferase. An essential enzyme in the gamma-glutamyl cycle. , 2008, The Journal of biological chemistry.
[54] G. Buchsbaum,et al. Incontinence and pelvic organ prolapse in parous/nulliparous pairs of identical twins , 2008, Neurourology and urodynamics.
[55] B. Chung,et al. Quantitative determination of progesterones and corticosteroids in human urine using gas chromatography/mass spectrometry: application to pelvic organ prolapse patients. , 2008, Rapid communications in mass spectrometry : RCM.
[56] L. D. White,et al. Identification of murine uterine genes regulated in a ligand-dependent manner by the progesterone receptor. , 2005, Endocrinology.
[57] A. O'Boyle,et al. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. , 2005, American journal of obstetrics and gynecology.
[58] K. Nose,et al. Invasive Potential Induced under Long-Term Oxidative Stress in Mammary Epithelial Cells , 2004, Cancer Research.
[59] C. Bradley,et al. Pelvic Organ Prolapse in Older Women: Prevalence and Risk Factors , 2004, Obstetrics and gynecology.
[60] A. Visvikis,et al. The changing faces of glutathione, a cellular protagonist. , 2003, Biochemical pharmacology.
[61] Pamela A. Moalli,et al. Risk Factors Associated With Pelvic Floor Disorders in Women Undergoing Surgical Repair , 2003, Obstetrics and gynecology.
[62] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[63] L. Brubaker,et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. , 1996, American journal of obstetrics and gynecology.
[64] R. Grantham. Amino Acid Difference Formula to Help Explain Protein Evolution , 1974, Science.
[65] F. E. Grubbs. Procedures for Detecting Outlying Observations in Samples , 1969 .
[66] A. Heintz,et al. Measuring health‐related quality of life in women with urogenital dysfunction: The urogenital distress inventory and incontinence impact questionnaire revisited , 2003, Neurourology and urodynamics.